Evaluating the Optimal Sequence of Treatment With Egfr Inhibitors and Bevacizumab in Ras Wild-Type Metastatic Colorectal Cancer
AuthID
P-00W-E0E
P-00W-E0E
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service